Thousands Denied Compensation as Purdue Opioid Settlement Fails Many Victims

Mary Jannotta, a 77-year-old Pennsylvania resident, worked for decades slicing meat and cheese in suburban supermarkets. After a botched back surgery in 2008, she was prescribed OxyContin, Purdue Pharma’s powerful opioid painkiller. What began as a treatment for her pain quickly turned into a dependence on the drug. Cut off by her doctors, Jannotta resorted to purchasing pills illegally in Kensington, Philadelphia’s dangerous open-air drug market. Her struggle led to losing her car, home, and ultimately, her grandson, Tyler Cordeiro, who died of an overdose at 24.

Jannotta was among nearly 140,000 individuals who filed claims against Purdue Pharma during its bankruptcy proceedings in 2019, seeking justice for the harm caused by its opioids. However, after years of waiting and a Supreme Court rejection of the initial settlement, a revised $7.4 billion plan was approved last November. Despite this, fewer than half of those who filed will receive any compensation under the new terms.

The updated plan drastically reduced payouts, imposed stricter eligibility requirements, and eliminated compensation for teenagers who bought Purdue opioids illegally. For families of overdose victims, settlements dropped from $48,000 to as little as $8,000. Perhaps most critically, the new plan removed a provision allowing victims to submit sworn affidavits in place of medical or legal records to prove opioid use. This change disproportionately harms individuals like Ellen Isaacs, whose son Ryan died of an overdose at 33. Isaacs explained that prescription records from years ago are unavailable, leaving her unable to qualify for compensation.

The revised settlement was negotiated behind closed doors, with key details buried in thousands of pages of court filings. Victims were left blindsided by the changes, which were approved without significant media attention or public scrutiny. The legal process also introduced multiple deadlines, including a final filing date in September 2021, after which many claims were excluded from payouts. By July 2025, only about 63,000 of nearly 140,000 claimants had met the stringent new requirements, leaving thousands without any form of compensation.

The outcome has left opioid victims feeling betrayed, as the settlement fails to deliver on its promise of meaningful justice for those harmed by Purdue’s opioids.